Annoroad Gene Technology, headquartered in Beijing's E-Town Biomedical Park, will work together with Illumina to develop a next-gen non-invasive prenatal DNA diagnostic test for the China market. Annoroad will contribute its expertise with nucleic acid extraction, library preparation, and data analysis software, while Illumina will provide next generation sequencing instruments and related reagents. Their goal is to create a highly accurate, easy-to-use system.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
